BIOCON
|
|
BOM : 532523     NSE : BIOCON     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Average |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 29,2022 |
Price(EOD): ₹ 310.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 37,254.62 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
BIOCON | -5% | -7.2% | -20.3% |
SUN PHARMACEUTICAL INDUSTRIES | 1.6% | -2.6% | 23.2% |
DIVIS LABORATORIES | -2.2% | -0.2% | -14.5% |
DR REDDYS LABORATORIES | 1.6% | -0.1% | -17.5% |
CIPLA | 1.4% | -4.9% | -1.2% |
GLAND PHARMA | 1.7% | -7.3% | -17.1% |
PIRAMAL ENTERPRISES | 2.1% | -12.2% | -30.3% |
CADILA HEALTHCARE | 2.9% | -5.9% | -42.7% |
TORRENT PHARMACEUTICALS | -0.5% | -0.3% | -0.1% |
FUNDAMENTAL ANALYSIS OF BIOCON
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF BIOCON
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
50.29
P/E Calculated based on EPS of 6.17
[ Mar2021 - Consolidated Results ] 4.98
P/B Calculated based on Book Value of 62.27
[ Mar2021 - Consolidated Results ] 4.55
P/S Calculated based on Revenues of 8184 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
113% 6% 1% |
SHARE PRICE MOMENTUM OF BIOCON
BIOCON vs SENSEX
DEBT OF BIOCON
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0 0 0.01 - |
0.58 0.4 0.4 0.46 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF BIOCON
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF BIOCON
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
10.79% 21.24% 25.12% 26.27% |
30.76% 35.85% -9.18% -7.98% |
QtrlyTrend |
4 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
BIOCON related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE MIDSMALLCAP | 3.9% | -4.9% | -0.9% |
S&P BSE MID CAP | 3.3% | -5% | -2% |
S&P BSE ALLCAP | 3% | -5.2% | -0.1% |
S&P BSE 500 | 2.9% | -5.2% | -0.3% |
S&P BSE MIDCAP SELECT INDEX | 2.8% | -5.1% | -1.1% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY500 MULTICAP 50:25:25 | 3.2% | -5.2% | -0.5% |
NIFTY LARGE MIDCAP 250 | 3.2% | -5% | 0.2% |
NIFTY 500 | 2.8% | -5.2% | -0.4% |
NIFTY 100 EQUAL WEIGHT | 2.8% | -5.3% | -2.5% |
NIFTY NEXT 50 | 2.7% | -5.8% | -4.3% |
You may also like the below Video Courses
FAQ about BIOCON
Is BIOCON good for long term investment?
As on Jun 29,2022, the Fundamentals of BIOCON look Strong and hence it may be good for long term investment! See Financial Performance of BIOCON . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is BIOCON UnderValued or OverValued?
As on Jun 29,2022, BIOCON is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of BIOCON ?
As on Jun 29,2022, the Intrinsic Value of BIOCON is Rs. 291.43 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 145.97
Fair Value [Median EV / Sales Model] : Rs. 291.43
Fair Value [Median Price / Sales Model] : Rs. 306.58
Median Fair Value of BIOCON : Rs. 291.43
Is BIOCON trading at a Premium or Discount?
As on Jun 29,2022, BIOCON is trading at a Premium of 6% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
